Antiemetic use among pregnant women in the United States: the escalating use of ondansetron
Lockwood G. Taylor(United States Food and Drug Administration), Sengwee Toh(Harvard University), Marsha E. Reichman(National Cancer Institute), Steven T. Bird(Brigham and Women's Hospital), Katherine Haffenreffer(Harvard University), Leyla Şahin, Patty Greene(United States Food and Drug Administration), Melissa S. Tassinari(United States Food and Drug Administration), Susan E. Andrade(University of Massachusetts Chan Medical School)
Cited by 63
Related Papers
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
|Journal of Clinical Oncology|2009|1.7k
Effects of Alcohol Consumption on Plasma and Urinary Hormone Concentrations in Premenopausal Women
|JNCI Journal of the National Cancer Institute|1993|399
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers
|American Journal of Obstetrics and Gynecology|2013|118
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93